WHO requires ‘more than a press release’ to evaluate AstraZeneca vaccine

Published November 27, 2020 7:46pm ET



The World Health Organization said its immunology team has yet to receive crucial information from the company about its coronavirus vaccine trial results.

WHO’s Department of Immunization, Vaccines, and Biologicals needs access to full clinical trial results for the vaccine developed by AstraZeneca and researchers at the University of Oxford. Dr. Katherine O’Brien, director of the Immunization, Vaccines, and Biologicals department said at the Friday media briefing that “what we have seen is a press release.”

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.